Among these, NfL and tau proteins, detectable in blood or CSF, as well as phosphodiesterase 10A (PDE10A) measured by positron emission tomography (PET), have been shown to be useful in diagnosing and predicting HD clinical prognosis [124,125]. Here, MAPT is linked to Huntington disease.